Why This Matters
- 10–15% of healthcare workers misuse substances during their career.
- Most facilities only uncover diversion after regulators or lawsuits.
- False alerts waste hundreds of compliance hours.
- Workflow blind spots (e.g., meds bypassing ADCs, OR not charting electronically) leave entire areas unmonitored.
“Having software” ≠ “Having a defensible diversion program.”
Already Have Diversion Software?
Buying the software is just the start.
Most hospitals we see already own a diversion tool — but don’t know if it’s working.
That’s where Rxpert Solutions comes in:
- Validate feeds so no data goes missing.
- Tune the logic so your team isn’t buried in false positives.
- Train staff to recognize diversion signals before regulators do.
- Build workflows that withstand audits and litigation.
We’ll help you get full value from the system you already invested in.
The 2025 Vendor Landscape: Strengths & Blind Spots
We reviewed the four most visible diversion software vendors in today’s market.
Each has strengths. Each leaves blind spots.
Your text
Email Accounts
Monthly Bandwidth
Control Panel
Databases
Wolters Kluwer (Sentri7 + Invistics AI)
Bluesight (ControlCheck + Medacist + Protenus)
HelioMetrics
Anigent
Advantages
Enterprise-wide platform with AI-powered diversion detection.
Market leader (~40% share, Best-in-KLAS).
Fully customizable, vendor-agnostic dashboards.
Built by a diversion specialist pharmacist.
Moderate Considerations
Trusted by 700+ hospitals.
Comprehensive “Medication Intelligence” suite.
Smaller independent innovator.
Includes waste assay analysis.
Risks
Manual workflow burden → staff fatigue risks missed cases.
Alert fatigue → real diversion buried in false positives.
Adoption pace is slow; limited data on outcomes.
Limited market presence; narrow adoption.
Why Facilities Partner With Rxpert Solutions
Drug Diversion Monitoring as a Service (DMaaS) ensures your program works in practice — not just on paper.
Validate feeds, tune alerts, and reduce false positives.
Build investigation workflows that hold up under scrutiny.
Train staff to spot diversion early and act fast.
Anyone saying ‘just turn on the software’ is mistaken. Ongoing monitoring, interpretation, and response are required.
ROI & Compliance Protection
Direct costs
legal defense, settlements, remediation.
Indirect costs
loss of reputation, staff trust, reduced census.
True ROI
Software + oversight = earlier detection, fewer false positives, protected revenue.
A diversion scandal costs millions. A one-hour risk assessment costs nothing.
5 Questions Every Facility Should Ask Before Choosing a Vendor
- Does the system integrate with all my medication workflows?
- How does it score risk and reduce false positives?
- Can it adapt as regulations evolve?
- How much staff time will investigations actually require?
- What independent oversight ensures defensibility?
